Cognition Therapeutics Aligns With FDA On Key Elements Of Phase 3 Study In Dementia With Lewy Bodies Including Patient Selection, Dose, Duration, And Endpoints

Benzinga

2026.10.22 10:02 (GMT+0)

Abrir en Benzinga